Daewoong's Nabota, which contains botulinum toxin, is expanding its presence in the foreign market. Its export amount surpassed KRW 100 billion up to Q3 2024. Over 80% of the overall sales were accounted for by sales generated in the foreign market. It is a cash cow export product.

According to Daewoong on November 2, Nabota generated sales of KRW 47.5 billion in Q3, up 25.0% from KRW 38 billion Year-over-Year (YoY). Nabota's domestic sales amounted to KRW 7.2 billion in Q3, down 2.7% from the previous year. The export amount increased to KRW 40.3 billion, up 31.7%. Nabota's cumulative sales were KRW 137.8 billion in Q3, an increase of 21.6% from the previous year.